{"transactions":[{"id":919251,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-04T16:10:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 2, 2026 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2026, subject to the reporting person's continued service on each such vesting date."}],"balance_after":170000,"derivative":{"exercise_price":10.72,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001193125-26-037574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000119312526037574/ownership.xml","form_type":"4"}},{"id":1082743,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:38:33.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098043","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017025098043/ownership.xml","form_type":"4"}},{"id":1292930,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-28T16:15:14.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2025 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2025, subject to the reporting person's continued service on each such vesting date."}],"balance_after":285000,"derivative":{"exercise_price":4.16,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0000950170-25-009818","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000095017025009818/ownership.xml","form_type":"4"}},{"id":1340312,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:32:48.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134145/ownership.xml","form_type":"4"}},{"id":1425181,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:05:58.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024099833/ownership.xml","form_type":"4"}},{"id":1666415,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-30T21:05:10.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":6.95,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-009094","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000095017024009094/ownership.xml","form_type":"4"}},{"id":1675096,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T16:15:05.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":61822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This performance-based stock option was granted on August 7, 2023 and is subject to the achievement of certain pre-defined performance objectives pertaining to financial and investor relations goals within six months from the grant date, and subject to Mr. Musso continuing to be an \"eligible participant\" (as defined in Fulcrum Therapeutics, Inc.'s 2022 Inducement Stock Incentive  Plan) through the vesting date. All performance objectives were met on January 17, 2024."}],"balance_after":61822,"derivative":{"exercise_price":4.01,"exercise_date":"2024-02-07","expiration_date":"2033-08-06","underlying":"Common Stock","underlying_shares":61822},"source":{"system":"sec-edgar","filing":"0000950170-24-005790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000095017024005790/ownership.xml","form_type":"4"}},{"id":1751194,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T00:53:07.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service."}],"balance_after":5450,"derivative":{"exercise_price":1.17,"expiration_date":"2033-10-30","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0000899243-23-020116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924323020116/doc4.xml","form_type":"4"}},{"id":1811873,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T16:16:29.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":432800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 7, 2023 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 7, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":432800,"derivative":{"exercise_price":4.01,"expiration_date":"2033-08-06","underlying":"Common Stock","underlying_shares":432800},"source":{"system":"sec-edgar","filing":"0000950170-23-040615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000095017023040615/ownership.xml","form_type":"4"}},{"id":3872481,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-05T16:03:57.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":52500,"derivative":{"exercise_price":7.72,"expiration_date":"2028-07-01","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001358403-18-000076","document":"wf-form4_153082102092716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000076/wf-form4_153082102092716.xml","form_type":"4"}},{"id":3915255,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-05-29T16:49:59.000Z","date":"2018-05-25","kind":"sale","acquired":false,"shares":6206,"price":7.9707,"value":49466.1642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on June 7, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 18, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.96 to $8.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth above."}],"balance_after":26548,"source":{"system":"sec-edgar","filing":"0001358403-18-000050","document":"wf-form4_152762693514280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000050/wf-form4_152762693514280.xml","form_type":"4"}},{"id":4105307,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2018-01-05T16:04:16.000Z","date":"2018-01-03","kind":"exercise","acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU\") represents a contingent right to receive one share of BLCM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2017, the reporting person was granted 7,500 RSUs, of which 1,875 vested on January 3, 2018. The RSUs vest in four equal annual installments beginning January 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2017, the reporting person was granted 7,500 RSUs, of which 1,875 vested on January 3, 2018. The RSUs vest in four equal annual installments beginning January 3, 2018."}],"balance_after":5625,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001358403-18-000018","document":"wf-form4_151518624289946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000018/wf-form4_151518624289946.xml","form_type":"4"}},{"id":4105306,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-01-05T16:04:16.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":706,"price":9.79,"value":6911.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 7,500 shares."}],"balance_after":32754,"source":{"system":"sec-edgar","filing":"0001358403-18-000018","document":"wf-form4_151518624289946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000018/wf-form4_151518624289946.xml","form_type":"4"}},{"id":4105305,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-01-05T16:04:16.000Z","date":"2018-01-03","kind":"exercise","acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU\") represents a contingent right to receive one share of BLCM common stock."}],"balance_after":33460,"source":{"system":"sec-edgar","filing":"0001358403-18-000018","document":"wf-form4_151518624289946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000018/wf-form4_151518624289946.xml","form_type":"4"}},{"id":4107235,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2018-01-04T16:01:56.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of BLCM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 2, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 2, 2019."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001358403-18-000006","document":"wf-form4_151509970144349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000006/wf-form4_151509970144349.xml","form_type":"4"}},{"id":4107234,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-04T16:01:56.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":22500,"derivative":{"exercise_price":9.23,"expiration_date":"2028-01-01","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001358403-18-000006","document":"wf-form4_151509970144349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840318000006/wf-form4_151509970144349.xml","form_type":"4"}},{"id":4133217,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-12-13T16:05:42.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":17117,"price":9.328,"value":159667.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on June 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.13 to $9.52. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth above."}],"balance_after":31585,"source":{"system":"sec-edgar","filing":"0001358403-17-000171","document":"wf-form4_151319912870666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840317000171/wf-form4_151319912870666.xml","form_type":"4"}},{"id":4148904,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-11-29T17:06:00.000Z","date":"2017-11-27","kind":"sale","acquired":true,"shares":6206,"price":9.8908,"value":61382.3048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on June 7, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.85 to $9.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth above."}],"balance_after":48702,"source":{"system":"sec-edgar","filing":"0001358403-17-000169","document":"wf-form4_151199314620395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840317000169/wf-form4_151199314620395.xml","form_type":"4"}},{"id":4261653,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-06T16:09:58.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":31500,"derivative":{"exercise_price":11.7,"expiration_date":"2027-07-02","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001358403-17-000129","document":"wf-form4_149937178498083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840317000129/wf-form4_149937178498083.xml","form_type":"4"}},{"id":4302807,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-05-26T15:07:07.000Z","date":"2017-05-25","kind":"sale","acquired":false,"shares":6311,"price":12.2411,"value":77253.5821,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 671 shares acquired under the Issuer's Employee Stock Purchase Plan on December 9, 2016."}],"balance_after":54908,"source":{"system":"sec-edgar","filing":"0001358403-17-000079","document":"wf-form4_149582561230485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840317000079/wf-form4_149582561230485.xml","form_type":"4"}},{"id":4498223,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2017-01-05T19:16:25.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of BLCM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2018."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001358403-17-000017","document":"wf-form4_148366177302043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840317000017/wf-form4_148366177302043.xml","form_type":"4"}},{"id":4498222,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-01-05T19:16:25.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable on January 3, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":13500,"derivative":{"exercise_price":13.89,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001358403-17-000017","document":"wf-form4_148366177302043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840317000017/wf-form4_148366177302043.xml","form_type":"4"}},{"id":4540070,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2016-11-29T16:05:10.000Z","date":"2016-11-28","kind":"sale","acquired":false,"shares":600,"price":19.845,"value":11907.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on December 22, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.72 to $20.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":60548,"source":{"system":"sec-edgar","filing":"0001358403-16-000294","document":"wf-form4_148045349793060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840316000294/wf-form4_148045349793060.xml","form_type":"4"}},{"id":4540069,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2016-11-29T16:05:10.000Z","date":"2016-11-28","kind":"sale","acquired":false,"shares":22427,"price":19.2292,"value":431253.2684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on December 22, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.71 to $19.6826. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":61148,"source":{"system":"sec-edgar","filing":"0001358403-16-000294","document":"wf-form4_148045349793060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840316000294/wf-form4_148045349793060.xml","form_type":"4"}},{"id":4540068,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":30974,"kind":"person","name":"Musso Alan A","position":1,"cik":"0001295830","reported_name":"Musso Alan A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Common Stock","published_at":"2016-11-29T16:05:10.000Z","date":"2016-11-25","kind":"sale","acquired":false,"shares":6273,"price":20.4815,"value":128480.4495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on December 22, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.23 to $20.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 665 shares acquired under the Issuer's Employee Stock Purchase Plan, the \"ESPP\" on June 10, 2016; and 441 shares acquired under the ESPP on December 10, 2015."}],"balance_after":83575,"source":{"system":"sec-edgar","filing":"0001358403-16-000294","document":"wf-form4_148045349793060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1295830/000135840316000294/wf-form4_148045349793060.xml","form_type":"4"}}]}